Will OpenAI or Anthropic IPO first?

**Stage 1 — Blind analysis (ignore market price):**

OpenAI and Anthropic are both large, well‑funded, and have stated cultural preferences against early IPOs, but they differ materially in commercial traction, investor composition, and strategic relationships. OpenAI today (mid‑2026 context) is the more widely monetized and enterprise‑penetrated of the two: its ChatGPT/enterprise product family, embedded distribution through a major cloud/strategic partner, and multiple revenue lines make a public offering a straightforward, marketable story once company leadership decides the timing is right. Anthropic has differentiated itself on safety and research posture and has been more circumspect about product release cadence and public‑market pressure; it is less obviously positioned today as a revenue machine on the same scale (though it may well accelerate).

Companies that are already generating large, visible revenue streams and that have clear paths to recurring cash flow almost always have a lower barrier to IPO execution than deeply research‑oriented or governance‑constrained peers. OpenAI’s governance structure (capped‑profit LP controlled by a nonprofit) adds complexity, but complexity is a solvable accounting and disclosure problem; it increases friction and timeline risk but does not negate the stronger commercial incentives pushing OpenAI toward a public exit earlier. Anthropic’s safety‑first posture and investor preferences make it more likely to postpone a public listing unless market conditions or a liquidity window (secondary market demand, large tender offer, or strategic investor exit) creates strong pressure.

We should also weigh non‑linear events that can reorder timelines: a large acquisition offer, a regulatory enforcement action, or a major safety incident could accelerate or decisively delay either company’s IPO plans. A strategic investor (e.g., a large cloud provider) could either block, buy out, or push a company public depending on its objectives. Historically, founders’ statements against IPOs matter for short‑run expectations but are poor predictors over multi‑decade horizons: positions change when capital needs, investor exit horizons, or strategic landscape change.

Putting these elements together, blind of current market price, my judgment is that OpenAI is materially more likely to be the first of the two to complete an IPO before 2040. I quantify that as ~72%: high but not certain, because structural complexities, founder preferences, possible acquisitions, or regulatory shocks could easily flip the order.

**Stage 2 — Market calibration (incorporating current market price):**

Current market price: Yes = 80%, No = 20% (market strongly favors OpenAI going first). My independent 72% is lower than the market by ~8 percentage points. The market’s premium on OpenAI likely reflects visible revenue scale, brand dominance, and intuitive instincts that the more commercially active company lists first. Those are legitimate signals; however, the market may underweight the following countervailing facts: the unusual governance structure of OpenAI (which complicates S‑1 disclosures and could delay or reshape an offering), Sam Altman and leadership statements resisting short‑term IPOs, and the persistent possibility of a strategic buyout or long‑term private financing that removes the need to list. Conversely, the market could be appropriately pricing in private information or faster commercialization at Anthropic that I don’t see—if so, my 72% would be conservative.

Practical outcome for traders: given the market at 80% and my independent estimate at 72%, the market appears modestly overconfident about OpenAI’s lead. If you accept my read, selling Yes (or buying No) is the value trade. If you believe near‑term cash flows, partner pressure, or private intel pushing an even earlier OpenAI IPO exist, the market price could be fair or underpriced.

Overall calibration: the market is directionally correct in favoring OpenAI, but it likely overstates confidence by a small margin given structural and governance uncertainties that can delay an OpenAI IPO or flip sequencing via acquisition or other corporate actions.